About Gammagard Dosing
The Gammagard Dose Calculator is a clinical support tool intended for healthcare professionals to aid in determining appropriate dosing, volume, and infusion parameters for Gammagard Liquid [Immune Globulin Infusion (Human)] 10%. The calculations are based on the FDA-approved prescribing information for its specified indications.
Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not a substitute for professional clinical judgment, diagnosis, or treatment. Always consult the full, official prescribing information before making any clinical decisions.
Outputs Explained
After entering the required patient and clinical data, the calculator provides the following key outputs to guide administration:
- Total Dose (g): The complete dose of immune globulin in grams, calculated based on the patient’s dosing weight and the selected g/kg dose.
- Total Volume (mL): The corresponding fluid volume of the 10% solution (100 mg/mL) required for the total dose.
- Vial Combination: A suggested combination of available Gammagard Liquid vial sizes to achieve the required total volume with minimal waste.
- Infusion Schedule: A recommended titration schedule detailing infusion rates in mL/kg/hr and the calculated patient-specific rate in mL/hr for each step of the infusion.
How to Use the Calculator
To ensure accurate results, follow these steps when using the tool:
- Enter Patient Weight: Input the patient’s weight and select the appropriate unit (kg or lbs).
- Select Clinical Indication: Choose from the list of approved indications: Primary Immunodeficiency (PI), CIDP (Loading or Maintenance), or Multifocal Motor Neuropathy (MMN). An “Other” option is available for off-label considerations.
- Specify Dose (g/kg): The tool provides recommended dose ranges based on the selected indication. For PI and MMN, a dropdown with typical doses is available. For CIDP, doses are fixed. For “Other,” you can input a custom dose.
- Use Adjusted Body Weight (Optional): For certain patients, you can select the option to calculate the dose using Ideal Body Weight (IBW) or Adjusted Body Weight (AdjBW). This requires entering the patient’s height and sex.
Dosing Overview
The dosing for Gammagard Liquid is specific to the clinical indication. The calculator uses the following FDA-approved dosing regimens:
| Indication | Recommended Dose | Dosing Frequency |
|---|---|---|
| Primary Immunodeficiency (PI) | 0.3 to 0.6 g/kg | Every 3 to 4 weeks |
| CIDP (Loading Dose) | 2 g/kg | Administered in divided doses over up to 5 days |
| CIDP (Maintenance Dose) | 1 g/kg | Administered over 1 day (or divided into 2 consecutive days) every 3 weeks |
| Multifocal Motor Neuropathy (MMN) | 0.5 to 2.4 g/kg | Administered in divided doses over 2 to 5 consecutive days |
Switching Patients
When switching a patient from another intravenous immune globulin (IVIG) product to Gammagard Liquid, the initial dose and frequency should typically be the same as the previous IVIG treatment. The clinical response and serum IgG levels should be monitored to determine if dose adjustments are necessary.
Missed Dose Protocol
If a patient misses a scheduled infusion of Gammagard Liquid, the missed dose should be administered as soon as possible. The subsequent doses should then be rescheduled to maintain the original interval from the date of the most recent infusion. Consult with the prescribing physician for specific guidance.
Safety Alerts
Gammagard Liquid is associated with several important warnings and precautions. It is contraindicated in patients with a history of severe systemic or anaphylactic reactions to human immune globulin and in IgA-deficient patients with antibodies against IgA and a history of hypersensitivity.
Key Warnings:
- Thrombosis: Thromboembolic events may occur. Monitor patients with known risk factors for thrombosis.
- Renal Dysfunction/Failure: Acute renal dysfunction, osmotic nephrosis, and death may be associated with IVIG products, particularly those containing sucrose. Gammagard Liquid does not contain sucrose.
- Hyperproteinemia and Viscosity: Monitor for signs and symptoms of hyperproteinemia, increased serum viscosity, and hyponatremia.
- Aseptic Meningitis Syndrome (AMS): AMS may occur, typically beginning within several hours to 2 days following treatment.
Frequently Asked Questions (FAQ)
Why does the calculator offer an ‘Adjusted Body Weight’ option?
For some patients, particularly those who are obese, dosing based on actual body weight may lead to overdosing. Using adjusted or ideal body weight can provide a more appropriate dose by accounting for the distribution of immune globulin in lean body mass. This is an advanced feature and should be used based on clinical judgment.
What vial sizes does the calculator use for its recommendations?
The tool calculates the most efficient combination using standard Gammagard Liquid vial sizes: 10 mL, 25 mL, 50 mL, 100 mL, 200 mL, and 300 mL.
How does the infusion rate schedule differ by indication in the tool?
The calculator generates different maximum infusion rates. For PI and MMN, the maximum recommended rate is up to 8.0 mL/kg/hr. For CIDP, a higher maximum rate of up to 12.0 mL/kg/hr may be tolerated after the initial titration period, as per the prescribing information.
What is the concentration of Gammagard Liquid assumed by the tool?
The calculator is specifically designed for Gammagard Liquid 10% solution, which contains 100 mg of immune globulin per mL.
Why are the doses for CIDP loading and maintenance fixed?
The FDA-approved label for CIDP specifies a fixed dose of 2 g/kg for the initial loading course and 1 g/kg for subsequent maintenance infusions. The tool reflects this by pre-filling these values.
What happens if my calculated total volume falls between vial sizes?
The calculator’s algorithm rounds up to the next available vial combination to ensure the full prescribed dose can be administered, which may result in a slightly higher total volume from vials than the calculated dose volume.
Can this calculator be used for subcutaneous administration?
No. This tool is exclusively for calculating doses and infusion rates for intravenous (IV) administration of Gammagard Liquid 10%.
Does the calculator account for pediatric dosing?
The calculator performs weight-based calculations applicable to patients of any age for whom Gammagard is prescribed. However, clinical judgment is crucial, especially in neonates and infants, and the infusion rates and volumes must be carefully considered for smaller patients.
References
- GAMMAGARD LIQUID Prescribing Information. U.S. Food and Drug Administration. Takeda Pharmaceuticals America, Inc.
- Gammagard.com (Official Healthcare Professional Site). Takeda Pharmaceuticals.
- Drugs@FDA: Gammagard Liquid (NDA 125101). U.S. Food and Drug Administration.
- Perez, E. E., Orange, J. S., & Bonilla, F. (2018). Update on the use of immunoglobulin in human disease: A review of evidence. Journal of Allergy and Clinical Immunology, 141(5), 1669–1680.
